Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Pharmaceuticals
About Investor
Dr. Tim Kutzkey is a Managing Partner at The Column Group. He focuses on early-stage biotech investments—Seed through Series A—though specific investment amounts were not verified. Prior to venture investing, he was founding CEO of Peloton Therapeutics and held leadership roles at companies like Neurona and Surrozen, with a scientific background including a PhD and postdoctoral work at UC Berkeley.
Previous investments
Surrozen
50M |2020
50M |2019
33M |2017
Nura Bio
68M |2024
Atavistik Bio
60M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free